Available online 3 July 2025
Author links open overlay panel, , , , Section snippetsAbbreviationsARVsantiretrovirals
CBDcannabidiol
CYPcytochrome P450
DDIsdrug-drug interactions
ECDCEuropean Centre for Disease Prevention and Control
EMISEuropean Men-Who-Have-Sex-With-Men Internet Survey
GBLgamma-butyrolactone
GHBgamma-hydroxybutyrate
HIVhuman immunodeficiency virus
The increasing prevalence of chemsex constitutes a significant public health challenge. Chemsex, defined as the use of psychoactive substances in order to enhance and prolong sexual activity, is primarily associated with
Disclosure of interestThe authors declare that they have no competing interests.
References (14)A. Motulsky et al.Patient-initiated consultations in community pharmaciesRes Social Adm Pharm
(2021)
E. Amundsen et al.Chemsex among men who have sex with men: a systematic scoping review of research methodsJ Homosex
(2024)
EMIS-2017–The european men-who-have-sex-with-men internet survey–online(2019)
The EMIS Network. EMIS 2010: The european men-who-have-sex-with-men internet survey. Findings from 38 countries(2013)
L. De la Mora et al.and chemsex drugs get along? Potential drug-drug interactions in a cohort of people living with HIV who engaged in chemsex: a retrospective observational studyInfect Dis Ther
(2022)
N. Desai et al.An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systemsExpert Opin Drug Metab Toxicol
(2020)
G.J. Muirhead et al.Pharmacokinetic interactions between sildenafil and saquinavir/ritonavirBr J Clin Pharmacol
(2000)
There are more references available in the full text version of this article.
View full text© 2025 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Comments (0)